Risk Factors for Hospitalization and Transfusion Criteria in Patients With Dengue Virus Infection (NCT07007585) | Clinical Trial Compass
RecruitingNot Applicable
Risk Factors for Hospitalization and Transfusion Criteria in Patients With Dengue Virus Infection
Mexico100 participantsStarted 2025-08-01
Plain-language summary
This 3-year prospective observational study aims to identify clinical and laboratory risk factors associated with hospitalization in patients with confirmed dengue virus infection. It also seeks to analyze real-world transfusion practices and their outcomes. The study will be conducted in a second-level hospital in northern Mexico and will follow patients from emergency department entry to clinical resolution or hospital discharge.
Who can participate
Age range
5 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients aged ≥5 years
* Laboratory-confirmed dengue infection (NS1, IgM, or PCR)
* First contact at emergency or outpatient services
* Informed consent signed by the patient or legal guardian
Exclusion Criteria:
* Co-infection with other arboviruses or COVID-19
* Pre-existing hematologic or oncologic disease
* Refusal to sign informed consent
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Proportion of enrolled patients requiring hospitalization
Timeframe: Time Frame: Within 10 days of symptom onset
2
Clinical and laboratory risk factors associated with hospitalization
Timeframe: Within 10 days of symptom onset
Trial details
NCT IDNCT07007585
SponsorJose Ivan Rodriguez de Molina Serrano
Sponsor typeOTHER
Study typeOBSERVATIONAL
Primary completion2028-07-31
Contact for this trial
JOSE IVAN RODRIGUEZ DE MOLINA SERRANO, MD, MSc, Ph, Specialist